Eli Lilly And reported $1.65B in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2478M 434M
ALKERMES ALKS:US -34457000 7.87M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 181.11B 36.36B
Astrazeneca AZN:US 2.2B 673M
Baxter International BAX:US $ 432M 99M
Biogen BIIB:US $ 940.9M 409.4M
Bristol Myers Squibb BMY:US $ 3197M 9M
Catalent CTLT:US $ 261M 45M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Gilead Sciences GILD:US $ 2029M 868M
GlaxoSmithKline GSK:LN 181.6B 5.9B
Glaxosmithkline GSK:US 1.82B 600M
Horizon Pharma HZNP:US 147M 49.44M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
JAZZ PHA JAZZ:US 126.35M 38.8M
Johnson & Johnson JNJ:US $ 6941M 599M
Lannett LCI:US $ -23942000 3.64M
Medtronic MDT:US $ 1396M 271M
Merk MRK:US $ 5711M 652M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Novartis NOVN:VX 3.32B 176M
Novartis NVS:US 3.32B 176M
Perrigo Ordinary Shares PRGO:US $ 2.6M 20.5M
Pfizer PFE:US $ 12099M 2104M
Prestige Brands PBH:US $ 87.01M 9.59M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Revance Therapeutics RVNC:US $ -57842000 4.38M
Teva Pharmaceutical Industries TEVA:US 734M 55M
United Therapeutics UTHR:US $ 201.8M 86.2M
Zoetis ZTS:US $ 737M 57M